Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
1.150
-0.090 (-7.26%)
At close: Oct 2, 2026, 4:00 PM EDT
1.170
+0.020 (1.74%)
After-hours: Oct 2, 2026, 7:30 PM EDT
TVRD's stock price has decreased by -96.96% in the past year and price targets may not have had time to catch up.
Tvardi Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JonesTrading | JonesTrading | Buy Reiterates $12 → $10 | Buy | Reiterates | $12 → $10 | +769.57% | Sep 15, 2026 |
| Lucid Capital | Lucid Capital | Buy Initiates $6 → $14 | Buy | Initiates | $6 → $14 | +1,117.39% | Sep 8, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $9 | Buy | Maintains | $9 | +682.61% | Aug 21, 2026 |
Unknown Analyst Cantor Fitzgerald No rating | Cantor Fitzgerald | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 20, 2026 |
| BTIG | BTIG | Buy Maintains $5 | Buy | Maintains | $5 | +334.78% | Aug 20, 2026 |
| Barclays | Barclays | Sell Maintains $3 | Sell | Maintains | $3 | +160.87% | Aug 20, 2026 |
| Piper Sandler | Piper Sandler | Buy Upgrades $13 | Buy | Upgrades | $13 | +1,030.43% | Jul 8, 2026 |
| Raymond James | Raymond James | Buy Upgrades $10 | Buy | Upgrades | $10 | +769.57% | Jul 8, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.